Dogwood Therapeutics, Inc.

  • About
    • Corporate Profile
    • Leadership
    • Board of Directors
    • Corporate Presentation
  • Technology
    • NaV 1.7
    • Antiviral Combination
  • Diseases
    • CINP
    • Long Covid
    • Fibromyalgia
  • Pipeline
  • Clinical Trials
    • CINP 203
  • Investors
  • News

Governance Documents

Investors

Investors

  • Overview
  • News
    • Press Releases
    • Email Alerts
  • Events & Presentations
    • Events
    • Presentations
    • Shareholder Letters
    • Meeting
  • Governance
    • Overview
    • Leadership
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial & Stock Info
    • Overview
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Resources
    • Overview
    • IR Contacts
    • FAQ
    • Email Alerts
  • Governance

  • Overview
  • Leadership
  • Board of Directors
  • Board Committees
  • Governance Documents

Code of Ethics

Download Code of Ethics

Insider Trading Policy

Download Insider Trading Policy

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Governance Committee Charter

Download Nominating and Governance Committee Charter

Ethics Hotline Policy

Download Ethics Hotline Policy
  • Email Alerts
  • Contacts
  • RSS News Feed

© 2025 Dogwood Therapeutics, Inc.           Terms and Conditions Privacy Policy Social Media Guidelines